Form D · Biotechnology
Frontier Medicines Corp
South San Francisco, CA · CIK 0001783380
Offering snapshot reported Jul 12, 2021 · SEC filing
- Reported sold
- $88.5M Offering amount: $88.5M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 12, 2021 | Initial | $88,499,972 | No comparison | Not reported | SEC filing |
| Nov 6, 2020 | Amendment | $66,999,999 | $33,499,999vs Jul 29, 2019 | 31 | SEC filing |
| Jul 29, 2019 | Initial | $33,500,000 | No comparison | 31 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-405861
Source: Form D, filed Jul 12, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gregory Chow | Executive |
| Luke Evnin | Director |
| Johannes Hermann, Ph.D. | Executive |
| Othman Laraki | Director |
| Janwillem Naesens | Director |
| Chris Varma, Ph.D. | Director, Executive |
| Kevin Webster | Executive |
| Cameron Wheeler | Director |
| Jim Winkler | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
151 Oyster Point Boulevard Second Floor
South San Francisco, CA, 94080
South San Francisco, CA, 94080